LA JOLLA PHARMACEUTICAL CO Restructuring Charges
LA JOLLA PHARMACEUTICAL CO reported Restructuring Charges of $200.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2020-11-09
- LA JOLLA PHARMACEUTICAL CO restructuring charges for the quarter ending 2019-12-31 was $4.90M.
- LA JOLLA PHARMACEUTICAL CO restructuring charges for the quarter ending 2019-09-30 was $0.00.
- LA JOLLA PHARMACEUTICAL CO restructuring charges for the quarter ending 2019-06-30 was $0.00.
- LA JOLLA PHARMACEUTICAL CO restructuring charges for the quarter ending 2019-03-31 was $0.00.
- LA JOLLA PHARMACEUTICAL CO restructuring charges for fiscal 2019 was $4.90M, a 22.50% increase from fiscal 2018.
- LA JOLLA PHARMACEUTICAL CO restructuring charges for fiscal 2018 was $4.00M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-09 | |||
| 2019-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.90M derived: sum of 2 quarters · filed 2020-03-02 | $4.90M derived: sum of 3 quarters · filed 2020-03-02 | $4.90M 10-K · filed 2020-03-02 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-06 | |||
| 2018-12-31 | $4.00M 10-K · filed 2020-03-02 |